This website is an information resource intended for healthcare professionals within the UK with an interest in Qutenza (capsaicin 179mg patch). The content and management of this site is under the responsibility of Grünenthal Ltd.

By clicking on one of the links below, you are declaring and confirming that you are a healthcare professional within the UK and are in agreement with the terms of use and privacy policy. Healthcare professionals will be provided with access to Qutenza education modules and accreditation for its use.

This product is only available via Alliance Healthcare, and is subject to a risk minimisation plan in the form of a prescriber’s guide to Qutenza. Those wishing to use and indeed obtain Qutenza must demonstrate their understanding of the prescriber’s guide by becoming accredited. Please contact medical information at medicalinformationuk@grunenthal.com or call 0870 351 8960 if you have any queries.

This involves reading the material in question/viewing associated training material and completing a multiple choice questionnaire to demonstrate understanding.

This product is not to be dispensed directly to a patient as this is not to be applied by a patient themselves, rather by a trained HCP in an appropriately ventilated clinical environment.

Prescribing information is available on the relevant section of the website.

Sign in

NHS email address


If you are a patient
or carer looking for
information click below

More Info

Reporting adverse events (UK Healthcare Professionals):
Adverse events should be reported.

Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Grünenthal Ltd. on 0870 351 8960.

Reporting side effects (UK patients):
If you get any side effects you should talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of medicines.

September 2021 M-QZA-UK-08-21-0026